Miracle-dz/UniFAR-FTUs huggingface dataset:
Evaluation of a Blended Relapse Prevention Program for Anxiety and Depression in General Practice: Qualitative Study.

BACKGROUND Existing studies have yet to investigate the perspectives of patients and professionals concerning relapse prevention programs for patients with remitted anxiety or depressive disorders in primary care. User opinions should be considered when optimizing the use and implementation of interventions. OBJECTIVE This study aimed to evaluate the GET READY relapse prevention programs for patients with remitted anxiety or depressive disorders in general practice. METHODS Semistructured interviews (N=26) and focus group interviews (N=2) with patients and mental health professionals (MHPs) in the Netherlands were performed. Patients with remitted anxiety or depressive disorders and their MHPs who participated in the GET READY study were interviewed individually. Findings from the interviews were tested in focus group interviews with patients and MHPs. Data were analyzed using thematic analysis. RESULTS Participants were positive about the program because it created awareness of relapse risks. Lack of motivation, lack of recognizability, lack of support from the MHP, and symptom severity (too low or too high) appeared to be limiting factors in the use of the program. MHPs play a crucial role in motivating and supporting patients in relapse prevention. The perspectives of patients and MHPs were largely in accordance, although they had different perspectives concerning responsibilities for taking initiative. CONCLUSIONS The implementation of the GET READY program was challenging. Guidance from MHPs should be offered for relapse prevention programs based on eHealth. Both MHPs and patients should align their expectations concerning responsibilities in advance to ensure optimal usage. Usage of blended relapse prevention programs may be further enhanced by diagnosis-specific programs and easily accessible support from MHPs. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) RR2-10.1186/s12888-019-2034-6.
COVID‐19 antibody screening with SARS‐CoV‐2 red cell kodecytes using routine serologic diagnostic platforms

The Coronavirus disease 2019 (COVID‐19) pandemic is having a major global impact, and the resultant response in the development of new diagnostics is unprecedented. The detection of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has a role in managing the pandemic. We evaluated the feasibility of using SARS‐CoV‐2 peptide Kode Technology‐modified red cells (C19‐kodecytes) to develop an assay compatible with existing routine serologic platforms.
Adult Executive Functioning Inventory (ADEXI): Factor structure, convergent validity, and reliability of a Spanish adaptation

Abstract Although there are several ratings to assess Executive Functions (EF) in adults, most of these are lengthy and comprise items which describe extreme or pathologic behaviors (e.g., ADHD symptoms), proving inadequate for the assessment of EF in general population. The Adult Executive Functioning Inventory (ADEXI) seeks to assess EF taking these limitations into account. The aims of the present study were to analyze the factor structure, the convergent and divergent validity, and the reliability of a Spanish adaptation of the ADEXI in a non-clinical population. The Spanish adaptation of the ADEXI, the Interpersonal Reactivity Index (IRI), the Cognitive Flexibility Scale (CFS), and an adaptation of the Aggression Scale (AS) were administered to 369 healthy adults between 18 and 60-years-old. To analyze the factor structure of the ADEXI, Confirmatory Factor Analysis (CFA) was used. In addition, the relationship between the inventory and the IRI, the CFS and the AS was analyzed. Finally, Cronbach’s α index was calculated. CFA showed that the two-factor model including (1) Working memory and (2) Inhibition best fit the data. Significant correlations were found between the ADEXI scores and the CFS, the IRI and the AS, providing additional evidence of construct validity. The internal consistency of the ADEXI was high (α = 0.87). Taken together, our results indicate that the Spanish adaptation of the ADEXI shows satisfactory psychometric properties and would be a valid and reliable measure to assess EF in non-clinical populations both for clinical and research purposes.
Cardiac myosin super relaxation (SRX): a perspective on fundamental biology, human disease and therapeutics

ABSTRACT The fundamental basis of muscle contraction ‘the sliding filament model’ (Huxley and Niedergerke, 1954; Huxley and Hanson, 1954) and the ‘swinging, tilting crossbridge-sliding filament mechanism’ (Huxley, 1969; Huxley and Brown, 1967) nucleated a field of research that has unearthed the complex and fascinating role of myosin structure in the regulation of contraction. A recently discovered energy conserving state of myosin termed the super relaxed state (SRX) has been observed in filamentous myosins and is central to modulating force production and energy use within the sarcomere. Modulation of myosin function through SRX is a rapidly developing theme in therapeutic development for both cardiovascular disease and infectious disease. Some 70 years after the first discoveries concerning muscular function, modulation of myosin SRX may bring the first myosin targeted small molecule to the clinic, for treating hypertrophic cardiomyopathy (Olivotto et al., 2020). An often monogenic disease HCM afflicts 1 in 500 individuals, and can cause heart failure and sudden cardiac death. Even as we near therapeutic translation, there remain many questions about the governance of muscle function in human health and disease. With this review, we provide a broad overview of contemporary understanding of myosin SRX, and explore the complexities of targeting this myosin state in human disease. This article has an associated Future Leaders to Watch interview with the authors of the paper. Summary: A discussion of the role and regulation of myosin super relaxation in biology, evolution, human disease, and cardiac therapeutics.
Nail Psoriasis: Diagnosis, Assessment, Treatment Options, and Unmet Clinical Needs

Objective An estimated 40–50% of patients with psoriasis (PsO) have psoriatic nail disease, which is associated with and directly contributes to a greater clinical burden and worse quality of life in these patients. In this review, we examine how recent advances in the use of new diagnostic techniques have led to improved understanding of the link between nail and musculoskeletal manifestations of psoriatic disease (PsD; e.g., enthesitis, arthritis) and we review targeted therapies for nail PsO (NP). Methods We performed a literature search to identify which systemic therapies approved for the treatment of PsO and/or psoriatic arthritis (PsA) have been evaluated for the treatment of NP, either as a primary or secondary outcome. A total of 1546 articles were identified on February18, 2019, and evaluated for relevance. Results We included findings from 66 articles on systemic therapies for the treatment of NP in PsD. With several scoring systems available for the evaluation of psoriatic nail disease, including varied subtypes and application of the Nail Psoriasis Area Severity Index, there was a high level of methodological heterogeneity across studies. Conclusion NP is an important predictor of enthesitis, which is associated with the early stages of PsA; therefore, it is important for rheumatologists and dermatologists to accurately diagnose and treat NP to prevent nail damage and potentially delay the onset and progression of joint disease. Further research is needed to address the lack of both standardized NP scoring systems and well-defined treatment guidelines to improve management of PsD.
Direct oral anticoagulants in patients with antiphospholipid syndrome: a retrospective study in a real-life patient cohort

The current mainstay for the treatment of thrombotic antiphospholipid syndrome (APS) is anticoagulation with vitamin K antagonists (VKAs). The use of direct oral anticoagulants (DOACs) is under debate. We aimed to assess whether DOACs would be safe in APS patients presenting to the thrombosis clinic. A retrospective cohort study was conducted. All patients presenting to our thrombosis clinic between 2010 and 2017 with a diagnosis of APS taking either VKAs or DOACs were included. APS diagnosis was based on the revised Sapporo criteria. Clinical and laboratory data were collected from the electronic and physical patient files. Out of 200 patients, 81 received VKAs, and 119 DOACs. The two cohorts did not differ with regard to their initial clinical manifestation or additional prothrombotic risk factors. Only a small minority of patients was antiphospholipid antibody triple positive (VKA, 7.0% vs. DOAC, 4.2%). Numberofon-treatment events was low (3 vs. 2). The hazard ratio for any thromboembolic event for patients taking DOACs was 0.78 (95% confidence interval, 0.12–5.19). Treatment with DOACs was not associated with an increased risk of recurrent thromboembolism in comparison with VKAs in this retrospective study. Our observation supports the assumption that in nontriple positive (low risk) APS patients, DOACs might be safe. Prospective data are urgently needed.
Help-seeking pathways prior to referral to outpatient child and adolescent mental health services

Aim: To investigate parental help-seeking patterns prior to referral to outpatient child and adolescent mental health services (CAMHS), and whether type of symptoms or duration of mental health problems prior to referral influence help-seeking. Setting: Child mental health services in Denmark involve several sectors collaborating based on stepped-care principles. Access to CAMHS is free of charge but requires a formal referral. Methods: In this cross-sectional observational study, parents of 250 children were interviewed about pathways to outpatient CAMHS using the Children’s Services Interview. Results: The median parent-reported duration of mental health problems prior to referral to CAMHS was 6.0 (IQR 3.4–8.5) years for children referred for neurodevelopmental disorders compared to 2.8 (IQR 1.0–6.5) years for children referred for emotional disorders. Educational services were the first help-seeking contact for the majority (57.5%) but referrals to CAMHS were most frequently from healthcare services (56.4%), predominantly general practitioners. Educational services played a greater part in help-seeking pathways for children referred for neurodevelopmental disorders. Conclusion: The majority of children referred to CAMHS have mental health problems for years before referral. The delay in time-to-referral was most pronounced for children referred for neurodevelopmental disorders. Help-seeking pathways differ by symptom duration and type of symptoms.
A randomized, placebo-controlled, double-blinded clinical trial of colchicine to improve vascular health in people living with HIV

Supplemental Digital Content is available in the text Objectives: People living with HIV (PWH) experience an increased burden of coronary artery disease (CAD) believed to be related, in part, to an interplay of chronically increased inflammation and traditional risk factors. Recent trials suggest cardiovascular benefits of the anti-inflammatory, colchicine, in HIV-seronegative CAD patients. However, the impact of colchicine on impaired vascular health, as measured by coronary endothelial function (CEF), an independent contributor to CAD, has not been studied in PWH. We tested the hypothesis that colchicine improves vascular health in PWH. Design: This was a randomized, placebo-controlled, double-blinded trial in 81 PWH to test whether low-dose colchicine (0.6 mg daily) improves CEF over 8–24 weeks. Methods: Coronary and systemic endothelial function and serum inflammatory markers were measured at baseline, and at 8 and 24 weeks. The primary endpoint was CEF, measured as the change in coronary blood flow from rest to that during an isometric handgrip exercise, an endothelial-dependent stressor, measured with non-invasive MRI at 8 weeks. Results: Colchicine was well tolerated and not associated with increased adverse events. However, there were no significant improvements in coronary or systemic endothelial function or reductions in serum inflammatory markers at 8 or 24 weeks with colchicine as compared to placebo. Conclusions: In PWH with no history of CAD, low-dose colchicine was well tolerated but did not improve impaired coronary endothelial function, a predictor of cardiovascular events. These findings suggest that this anti-inflammatory approach using colchicine in PWH does not improve vascular health, the central, early driver of coronary atherosclerosis.
Incompetence of the Asian Longhorned Tick (Acari: Ixodidae) in Transmitting the Agent of Human Granulocytic Anaplasmosis in the United States

Abstract The Asian longhorned tick, Haemaphysalis longicornis Neumann (Acari: Ixodidae), was recently introduced into the United States and is now established in at least 15 states. Considering its ability for parthenogenetic propagation and propensity for creating high-density populations, there is concern that this tick may become involved in transmission cycles of endemic tick-borne human pathogens. Human granulocytic anaplasmosis (HGA) caused by Anaplasma phagocytophilum is one of the more common tick-borne diseases in the United States, especially in the northeastern and midwestern states. There is considerable geographical overlap between HGA cases and the currently known distribution of H. longicornis, which creates a potential for this tick to encounter A. phagocytophilum while feeding on naturally infected vertebrate hosts.Therefore, we evaluated the ability of H. longicornis to acquire and transmit the agent of HGA under laboratory conditions and compared it to the vector competence of I. scapularis. Haemaphysalis longicornis nymphs acquired the pathogen with the bloodmeal while feeding on infected domestic goats, but transstadial transmission was inefficient and PCR-positive adult ticks were unable to transmit the pathogen to naïve goats. Results of this study indicate that the Asian longhorned tick is not likely to play a significant role in the epidemiology of HGA in the United States.
ARBUSCULAR MYCORRHIZAL COLONIZATION DOES NOT ALLEVIATE SODIUM CHLORIDE-SALINITY STRESS IN VINCA [CATHARANTHUS ROSEUS (L.) G. DON]

We conducted a study to determine if inoculation with arbuscular mycorrhizal fungi (AMF) would enhance the tolerance of vinca [Catharanthus roseus (L.) G. Don] plants to sodium chloride (NaCl)-induced salinity in irrigation water. Vinca tolerated salinity levels up to 40 mM. Chlorophyll concentration, proline synthesis, and total antioxidant activity were increased with saline irrigation, while leaf potassium (K), calcium (Ca), magnesium (Mg), iron (Fe), and boron (B) content decreased, suggesting a detrimental salinity effect. Despite the limited effect of increasing salinity on N content, NaCl-stressed vinca plants showed a marked decrease in nitrate reductase activity, which was associated with decreased leaf K and Fe total content. Mycorrhizal inoculation resulted in reduced growth when compared to non-AMF plants, regardless of salinity level. The K/sodium (Na) ratio decreased dramatically with increasing salinity regardless of AMF treatment. Suggesting, that the AMF isolate was not able to selectively uptake K and Ca, and avoid uptake of Na.
Synthesis and Characterization of Gold/Polypyrrole Core−Shell Nanocomposites and Elemental Gold Nanoparticles Based on the Gold-Containing Nanocomplexes Prepared by Electrochemical Methods in Aqueous Solutions

We report here the first electrochemical pathway to prepare Au-containing nanocomplexes with the mean diameter of 2 nm in 0.1 N KCl aqueous solutions without addition of any stabilizer. Encouragingly, polypyrrole- (PPy-) coated gold nanocomposites with a core−shell structure and a diameter smaller than 8 nm can be prepared by the formation of self-assembled monolayers and further orderly autopolymerization of pyrrole monomers on these nanocomplexes. The prepared Au/PPy nanocomposites should exhibit extremely high conductivity, as indicated by the analyses of X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), and surface-enhanced Raman scattering (SERS). Meanwhile, elemental Au(0) nanoparticles of a mean diameter of 5 nm can be obtained by treating the Au/PPy-nanocomposites-containing solution with sonification.
Hemifacial Microsomia: Clinical Features and Associated Anomalies

Supplemental Digital Content is available in the text Abstract Hemifacial microsomia (HFM) is the second most common congenital anomaly of the face after cleft lip and palate. There is a considerable variability in the extent and severity of affection of the bones and soft tissues of the face arising from these two arches. Different classification systems have been described for HFM with the mandible and/or the ear defects being key features needed for any classification system. Nowadays, the most widely used system is the orbital, mandibular, ear, facal nerve, soft tissue (OMENS) classification, later modified to the OMENS+ to include extracraniofacial manifestations. The aim of this study was to review the demographic characteristics and clinical findings of a group of Egyptian patients with HFM and to correlate the findings with data retrieved from the literature. Thirty-nine patients were identified and included in this study. Right side was predominantly affected in 19 patients (48.7%), 9 patients (23%) had left side affection (23%) and 11 patients (28.3%) had bilateral affection, with overall male-to-female ratio of 1:1.4. The majority of patients had a normal orbit (64%), mildly hypoplastic mandible with functioning temporomandibular joint (58% with type M1 or M2a), normal facial nerve (82%), and minimal to mild soft-tissue hypoplasia (52%). Significant ear deformity affected the bigger percentage of the patients (E3: 44%, E2: 14%) The data demonstrate the phenotypic variability of HFM and suggest a degree of relationship among the components of HFM. Some epidemiological aspects and clinical findings in our study did not always parallel those reported in western literatures. Small sample size is the main limitation of the study. Further, and if possible multi-center, studies are recommended.
Balance between geographic, soil, and host tree parameters to shape soil microbiomes associated to clonal oak varies across soil zones along a European North-South transect.

Tree root-associated microbiomes are shaped by geographic, soil physico-chemical, and host tree parameters. However, their respective impacts on microbiome variations in soils across larger spatial scales remain weakly studied. We out-planted saplings of oak clone DF159 (Quercus robur L.) as phytometer in four grassland field sites along a European North-South transect. After four years, we first compared the soil microbiomes of the tree root zone (RZ) and the tree root-free zone (RFZ). After, we separately considered the total microbiomes of both zones, besides the microbiome with significant affinity to the RZ, and compared their variability along the transect. Variations within the microbiome of the tree RFZ were shaped by geographic and soil physico-chemical changes, whereby bacteria responded more than fungi. Variations within both microbiomes of the tree RZ depended on the host tree and abiotic parameters. Based on perMANOVA and Mantel correlation tests, impacts of site specificities and geographic distance strongly decreased for the tree RZ affine microbiome. This pattern was more pronounced for fungi than bacteria. Shaping the microbiome of the soil zones in root proximity might be a mechanism mediating the acclimation of oaks to a wide range of environmental conditions across geographic regions. This article is protected by copyright. All rights reserved.
Interspecific protection against oxidative stress: green algae protect harmful cyanobacteria against hydrogen peroxide

Summary Oceanographic studies have shown that heterotrophic bacteria can protect marine cyanobacteria against oxidative stress caused by hydrogen peroxide (H2O2). Could a similar interspecific protection play a role in freshwater ecosystems? In a series of laboratory experiments and two lake treatments, we demonstrate that freshwater cyanobacteria are sensitive to H2O2 but can be protected by less‐sensitive species such as green algae. Our laboratory results show that green algae degrade H2O2 much faster than cyanobacteria. Consequently, the cyanobacterium Microcystis was able to survive at higher H2O2 concentrations in mixtures with the green alga Chlorella than in monoculture. Interestingly, even the lysate of destructed Chlorella was capable to protect Microcystis, indicating a two‐component H2O2 degradation system in which Chlorella provided antioxidant enzymes and Microcystis the reductants. The level of interspecific protection provided to Microcystis depended on the density of Chlorella. These findings have implications for the mitigation of toxic cyanobacterial blooms, which threaten the water quality of many eutrophic lakes and reservoirs worldwide. In several lakes, H2O2 has been successfully applied to suppress cyanobacterial blooms. Our results demonstrate that high densities of green algae can interfere with these lake treatments, as they may rapidly degrade the added H2O2 and thereby protect the bloom‐forming cyanobacteria.
Dynamic Joint Domain Adaptation Network for Motor Imagery Classification

Electroencephalogram (EEG) has been widely used in brain computer interface (BCI) due to its convenience and reliability. The EEG-based BCI applications are majorly limited by the time-consuming calibration procedure for discriminative feature representation and classification. Existing EEG classification methods either heavily depend on the handcrafted features or require adequate annotated samples at each session for calibration. To address these issues, we propose a novel dynamic joint domain adaptation network based on adversarial learning strategy to learn domain-invariant feature representation, and thus improve EEG classification performance in the target domain by leveraging useful information from the source session. Specifically, we explore the global discriminator to align the marginal distribution across domains, and the local discriminator to reduce the conditional distribution discrepancy between sub-domains via conditioning on deep representation as well as the predicted labels from the classifier. In addition, we further investigate a dynamic adversarial factor to adaptively estimate the relative importance of alignment between the marginal and conditional distributions. To evaluate the efficacy of our method, extensive experiments are conducted on two public EEG datasets, namely, Datasets IIa and IIb of BCI Competition IV. The experimental results demonstrate that the proposed method achieves superior performance compared with the state-of-the-art methods.